Medicine
18F-FDG PET in sarcoidosis: an observational study in 12 patients with infliximab
R. Keijsers, J. Verzijlbergen, D. V. Diepen, J. M. Bosch, J. Grutters
tlooto Summary
Changes imaged by 18F-FDG PET during infliximab treatment in sarcoidosis patients correlate with signs of clinical improvement to a considerate extent, which supports the hypothesis that 18F -FDG uptake represents disease activity.
Abstract
Abstract is not available.
Citation format
KEIJSERS, R., et al. 18F-FDG PET in sarcoidosis: An observational study in 12 patients with infliximab. SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2008, 25: 143.